Clinical Trial Update: Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the use of protamine to reverse heparin during/after catheter ablation for atrial fibrillation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Catheter Ablation

Drugs mentioned

• Protamine (protamine sulfate)

Snippet

Sponsor: University of Michigan | Conditions: Atrial Fibrillation, Catheter Ablation | Phase 4 | Status: COMPLETED | Results posted: 2018-10-23